Kelli M. Wilson
Papers
1
Total Citations
20
H-Index
1
About
Kelli M. Wilson is a biomedical researcher whose work focuses on high-throughput screening and drug combination discovery, particularly in the context of cancer therapeutics. Her most-cited paper, "High-Throughput Screening for Drug Combinations" (2019), has garnered 20 citations and represents a significant contribution to the field of precision medicine. In this work, Wilson developed and validated innovative methodologies for systematically identifying synergistic drug pairs, enabling more efficient and scalable approaches to combination therapy design. Her research addresses the critical challenge of drug resistance by exploring how multi-agent treatments can overcome compensatory pathways in tumors. Wilson's contributions have implications for both preclinical drug development and clinical translation, providing a framework for accelerating the discovery of effective combination regimens. Her work is notable for bridging the gap between high-throughput technology and actionable therapeutic insights, making her a rising voice in the integration of screening platforms with pharmacological modeling.
Research Focus
Key Achievements
Top Papers
- 1High-Throughput Screening for Drug Combinations20 citations · 2019